Experience

Nuvaira, Inc.

• United States
• Medical Device
• 1 - 100 Employee

• Vice President Science, Clinical, and R&D

  • Mar 2020 - Present

  Minneapolis, Minnesota, United States Manage and lead the Science, Clinical and R&D teams in the development and understanding of Nuvaira's technology from feasibility to regulatory approval. Develop and manage execution of short and long term strategic and operating plans for the Science, Clinical, and R&D functions. Manage others in the design and development of future commercial device from concept, through design control process, to regulatory approval. Manage others in the design and execution of Nuvaira's scientific… Show more Manage and lead the Science, Clinical and R&D teams in the development and understanding of Nuvaira's technology from feasibility to regulatory approval. Develop and manage execution of short and long term strategic and operating plans for the Science, Clinical, and R&D functions. Manage others in the design and development of future commercial device from concept, through design control process, to regulatory approval. Manage others in the design and execution of Nuvaira's scientific communication plan, through publications, conference abstracts, marketing activities and customer interactions. Manage Nuvaira's intellectual property portfolio

• Sr. Director, Science and Technology

  • Jan 2018 - Feb 2020

  Greater Minneapolis-St. Paul Area Manage a team of scientists, R&D engineers, biomedical engineers, and other technical specialists through bench-top and pre-clinical programs to develop Nuvaira's technology and understand how it interacts with target biologic tissues. Includes leading team members in the analysis of clinical data to determine the physiologic impact of Nuvaira's technology on our target patient population. Responsible for effective internal and external dissemination of these learnings.

• Manager, Science and Technology

  • May 2016 - Jan 2018

  Greater Minneapolis-St. Paul Area Supervise and lead team members through benchtop and or preclinical programs that evaluate Nuvaira's technology. Analyze clinical data to determine the clinical impact of Nuvaira's technology. Develop and manage execution of strategic plans for the use of clinical/preclinical data. Responsible for effective internal and external dissemination of learnings from benchtop, preclinical, and clinical programs.

• Senior Scientist

  • May 2013 - Apr 2016

  Greater Minneapolis-St. Paul Area Responsible for in depth and thoughtful analysis of preclinical and clinical data. Composition of scientific and technical writing of study summaries and reviews of the relevant literature for external and internal consumption. Act as an internal resource on the biological and mechanistic aspects of Nuvaria's technology.

• Consultant

  • Jan 2011 - May 2013

  Greater Minneapolis-St. Paul Area



Washington University School of Medicine in St. Louis

• Hospitals and Health Care
• 700 & Above Employee

• Assistant Professor, Director of the Peripheral Nerve Laboratory

  • May 2009 - May 2013

  Greater St. Louis Area Division of Plastic Surgery Department of Surgery Washington University School of Medicine



Miramar Labs

• Consultant

  • Mar 2011 - Mar 2012



Washington University in St. Louis

• United States
• Higher Education
• 700 & Above Employee

• Research Assistant

  • Aug 2004 - May 2009

  Greater St. Louis Area Doctoral experience •Led development and evaluation of biomaterial scaffold containing stem cells for spinal cord injury •Team Leader and coordinator in execution of protocols and experimental analysis Masters experience •Evaluated affinity based delivery system for controlled release of peripheral nerve growth stimulating protein •Worked within team to characterize release of protein and evaluate bioactivity following release



Saint Louis Univeristy

• Research Associate

  • Aug 2002 - Jul 2004

  Greater St. Louis Area •Encapsulation of delicate protein in biomaterial polymer matrix for peripheral nerve regeneration •Apart of team that evalluated the bioactivity and release characteristics of the encapsulated protein in in vitro model